{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:01:59Z","timestamp":1790762519083,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["CG-114-GP-02"],"award-info":[{"award-number":["CG-114-GP-02"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.lanwpc.2026.101970","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:38:04Z","timestamp":1787373484000},"page":"101970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Temporal patterns and risk factors of clozapine-associated neutropenia: a nationwide population-based cohort study"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2762-7295","authenticated-orcid":false,"given":"Chi-Shin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korinne","family":"Northwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Heng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lieh","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chung","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2072-9216","authenticated-orcid":false,"given":"Dan","family":"Siskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lanwpc.2026.101970_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first-and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br J Psychiatry"},{"issue":"12","key":"10.1016\/j.lanwpc.2026.101970_bib2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S2215-0366(25)00297-4","article-title":"Transdiagnostic effectiveness and safety of clozapine in individuals with psychotic, affective, and personality disorders: nationwide and meta-analytic comparisons with other antipsychotics","volume":"12","author":"Luykx","year":"2025","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"10.1016\/j.lanwpc.2026.101970_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S2215-0366(25)00031-8","article-title":"INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia","volume":"12","author":"McCutcheon","year":"2025","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101970_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/acps.12742","article-title":"International trends in clozapine use: a study in 17 countries","volume":"136","author":"Bachmann","year":"2017","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"10.1016\/j.lanwpc.2026.101970_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/acps.13280","article-title":"An evaluation of the variation and underuse of clozapine in the United Kingdom","volume":"143","author":"Whiskey","year":"2021","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"10.1016\/j.lanwpc.2026.101970_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/acps.12898","article-title":"Meta-analysis examining the epidemiology of clozapine-associated neutropenia","volume":"138","author":"Myles","year":"2018","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101970_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S2215-0366(23)00343-7","article-title":"Evaluating the epidemiology of clozapine-associated neutropenia among people on clozapine across Australia and Aotearoa New Zealand: a retrospective cohort study","volume":"11","author":"Northwood","year":"2024","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101970_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis: incidence and risk factors in the United States","volume":"329","author":"Alvir","year":"1993","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.lanwpc.2026.101970_bib9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1192\/bjp.169.4.483","article-title":"Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland","volume":"169","author":"Atkin","year":"1996","journal-title":"Br J Psychiatry"},{"issue":"6","key":"10.1016\/j.lanwpc.2026.101970_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S2215-0366(24)00097-X","article-title":"Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case\u2013control study in Finland","volume":"11","author":"Rubio","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.lanwpc.2026.101970_bib11","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1017\/S204579602200066X","article-title":"Clozapine haematological monitoring for neutropenia: a global perspective","volume":"31","author":"Oloyede","year":"2022","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1016\/j.lanwpc.2026.101970_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.psychres.2018.06.070","article-title":"The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: a systematic review","volume":"268","author":"Shah","year":"2018","journal-title":"Psychiatry Res"},{"issue":"8","key":"10.1016\/j.lanwpc.2026.101970_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jamapsychiatry.2025.1155","article-title":"FDA eliminates the clozapine REMS\u2014What comes next?","volume":"82","author":"Kelly","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101970_bib14","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1192\/j.eurpsy.2024.1816","article-title":"The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force","volume":"68","author":"Verdoux","year":"2025","journal-title":"Eur Psychiatry"},{"issue":"6","key":"10.1016\/j.lanwpc.2026.101970_bib15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/acps.70040","article-title":"Barriers to clozapine use in Europe: a new hope","volume":"152","author":"Verdoux","year":"2025","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.lanwpc.2026.101970_bib16","series-title":"PRAC Recommendations on Signals Adopted at the 7\u201310 July 2025 PRAC Meeting","year":"2025"},{"key":"10.1016\/j.lanwpc.2026.101970_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/20451253211072341","article-title":"Clozapine-and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study","volume":"12","author":"Johannsen","year":"2022","journal-title":"Ther Adv Psychopharmacol"},{"issue":"10","key":"10.1016\/j.lanwpc.2026.101970_bib18","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1177\/0004867417720516","article-title":"Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: a systematic review of the literature and clinical recommendations","volume":"51","author":"Myles","year":"2017","journal-title":"Aust N Z J Psychiatry"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101970_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1192\/bjp.188.3.255","article-title":"Rechallenge with clozapine following leucopenia or neutropenia during previous therapy","volume":"188","author":"Dunk","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.lanwpc.2026.101970_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/CLEP.S196293","article-title":"Taiwan's national health insurance research database: past and future","volume":"11","author":"Hsieh","year":"2019","journal-title":"Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.lanwpc.2026.101970_bib21","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.lanwpc.2026.101970_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/YIC.0000000000000270","article-title":"Clozapine-associated neutropenia in Latin America: incidence report of 5380 Chilean users","volume":"34","author":"Mena","year":"2019","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.lanwpc.2026.101970_bib23","series-title":"Psychosis and Schizophrenia in Adults: Prevention and Management","year":"2014"},{"issue":"9","key":"10.1016\/j.lanwpc.2026.101970_bib24","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1176\/appi.ajp.2020.177901","article-title":"The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia","volume":"177","author":"Keepers","year":"2020","journal-title":"Am J Psychiatry"},{"issue":"8","key":"10.1016\/j.lanwpc.2026.101970_bib25","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archinte.165.8.869","article-title":"Population-based drug-induced agranulocytosis","volume":"165","author":"Ib\u00e1\u00f1ez","year":"2005","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101970_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/JGP.0b013e3182118318","article-title":"Age and sex impact clozapine plasma concentrations in inpatients and outpatients with schizophrenia","volume":"20","author":"Ismail","year":"2012","journal-title":"Am J Geriatr Psychiatry"},{"issue":"10075","key":"10.1016\/j.lanwpc.2026.101970_bib27","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0140-6736(16)32380-7","article-title":"Socioeconomic status and the 25\u00d7 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1\u00b77 million men and women","volume":"389","author":"Stringhini","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101970_bib28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","article-title":"Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research","volume":"42","author":"DiMatteo","year":"2004","journal-title":"Med Care"},{"key":"10.1016\/j.lanwpc.2026.101970_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.schres.2017.08.041","article-title":"Sodium valproate and clozapine induced neutropenia: a case control study using register data","volume":"195","author":"Malik","year":"2018","journal-title":"Schizophr Res"},{"issue":"4","key":"10.1016\/j.lanwpc.2026.101970_bib30","first-page":"35","article-title":"Are clozapine blood dyscrasias associated with concomitant medications?","volume":"8","author":"Demler","year":"2011","journal-title":"Innov Clin Neurosci"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606526001744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606526001744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:15:35Z","timestamp":1790759735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606526001744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S2666606526001744"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101970","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal patterns and risk factors of clozapine-associated neutropenia: a nationwide population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101970"}}